Operating income changed across a sign change
Operating income changed +3891.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$241,000→$9.1M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →GDYN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 9.7%
Revenue changed +9.7% from the comparable as-filed period.
$104.2M→$114.3M2 prior comparisons
Capex / revenue moved 145 bp lower
Capex / revenue changed -145 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.87%→2.41%2 prior comparisons
Cash & equivalents decreased 10.1%
Cash & equivalents changed -10.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$338.6M→$304.3M2 prior comparisons
Free-cash-flow margin moved 877 bp higher
Free-cash-flow margin changed +877 basis points from the comparable as-filed period.
2.83%→11.60%2 prior comparisons
Operating cash-flow margin moved 732 bp higher
Operating cash-flow margin changed +732 basis points from the comparable as-filed period.
6.69%→14.01%2 prior comparisons
Receivables / revenue moved 547 bp lower
Receivables / revenue changed -547 basis points from the comparable as-filed period.
79.59%→74.12%2 prior comparisons
SBC / revenue moved 146 bp lower
SBC / revenue changed -146 basis points from the comparable as-filed period.
6.10%→4.65%2 prior comparisons
Research & development increased 13.2%
Research & development changed +13.2% from the comparable as-filed period.
$5.8M→$6.5M2 prior comparisons
Stock-based compensation decreased 16.5%
Stock-based compensation changed -16.5% from the comparable as-filed period.
$6.4M→$5.3M2 prior comparisons
Working capital decreased 6.1%
Working capital changed -6.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$382.9M→$359.7M4 prior comparisons
Current assets decreased 5.5%
Current assets changed -5.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$440.7M→$416.5M4 prior comparisons
Shares outstanding decreased 5.2%
Shares outstanding changed -5.2% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
84,769,058→80,370,1328 prior comparisons
Current ratio decreased 3.8%
Current ratio changed -3.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
7.63→7.344 prior comparisons
Cost of revenue decreased 1.8%
Cost of revenue changed -1.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$69.5M→$68.2M2 prior comparisons
Trade receivables increased 2.2%
Trade receivables changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$82.9M→$84.7M4 prior comparisons
Total assets decreased 1.8%
Total assets changed -1.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$613.2M→$602.3M4 prior comparisons
R&D / revenue moved 17 bp higher
R&D / revenue changed +17 basis points from the comparable as-filed period.
5.53%→5.70%2 prior comparisons
Current liabilities decreased 1.8%
Current liabilities changed -1.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$57.8M→$56.7M4 prior comparisons
Stock-based compensation decreased 34.1%
Stock-based compensation changed -34.1% from the comparable as-filed period.
$6.7M→$4.4M2 prior comparisons
Trade receivables increased 22.9%
Trade receivables changed +22.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$77.7M→$95.6M4 prior comparisons
SBC / revenue moved 255 bp lower
SBC / revenue changed -255 basis points from the comparable as-filed period.
6.64%→4.09%2 prior comparisons
Cash & equivalents decreased 11.4%
Cash & equivalents changed -11.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$336.8M→$298.4M2 prior comparisons
Operating income changed across a sign change
Operating income changed +1137.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$123,000→$1.3M2 prior comparisons
Working capital / assets moved 260 bp lower
Working capital / assets changed -260 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
61.47%→58.87%4 prior comparisons
Revenue increased 7.0%
Revenue changed +7.0% from the comparable as-filed period.
$101.1M→$108.2M2 prior comparisons
Operating cash-flow margin moved 858 bp lower
Operating cash-flow margin changed -858 basis points from the comparable as-filed period.
14.22%→5.64%2 prior comparisons
Free-cash-flow margin moved 776 bp lower
Free-cash-flow margin changed -776 basis points from the comparable as-filed period.
10.10%→2.33%2 prior comparisons
Receivables / revenue moved 1146 bp higher
Receivables / revenue changed +1146 basis points from the comparable as-filed period.
76.89%→88.35%2 prior comparisons
Working capital decreased 5.6%
Working capital changed -5.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$374.3M→$353.4M4 prior comparisons
Current assets decreased 5.2%
Current assets changed -5.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$433.0M→$410.3M4 prior comparisons
Capex / revenue moved 82 bp lower
Capex / revenue changed -82 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.13%→3.31%2 prior comparisons
Capital expenditure decreased 14.2%
Capital expenditure changed -14.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$4.2M→$3.6M3 prior comparisons
Gross profit increased 14.8%
Gross profit changed +14.8% from the comparable as-filed period.
$34.5M→$39.6M2 prior comparisons
Total assets decreased 1.4%
Total assets changed -1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$608.9M→$600.4M4 prior comparisons
Research & development decreased 4.8%
Research & development changed -4.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$6.7M→$6.4M2 prior comparisons
Shares outstanding decreased 4.2%
Shares outstanding changed -4.2% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
84,669,954→81,126,8818 prior comparisons
R&D / revenue moved 73 bp lower
R&D / revenue changed -73 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.67%→5.94%2 prior comparisons
Current liabilities decreased 3.2%
Current liabilities changed -3.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$58.7M→$56.9M4 prior comparisons
Cost of revenue increased 2.9%
Cost of revenue changed +2.9% from the comparable as-filed period.
$66.6M→$68.5M2 prior comparisons
Current ratio decreased 2.1%
Current ratio changed -2.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
7.37→7.224 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.